Get optimized quotes instantly for 35M+ unique compounds. Create a free account and start optimizing your compound procurement. Learn more »
MCULE-7601911172
Compound
Show structure
In order to add this molecule to a collection you have to create an account.
Sign up for free
- InChIKey:
- SMILES:
- InChI:
- Formula:
| Amount | Price
 Optimized compound price excluding delivery costs. Please note that automatic quote generation will optimize the total price based on your preferences.
|
Guaranteed purity (%) | Delivery time
Estimated door-to-door delivery time for EU and US customers. It will be refined and optimized during quote generation after the shipping country is specified.
|
|
|---|---|---|---|---|
| 1 mg | 77 USD | 95 | 9 working days | Get Quote |
| 5 mg | 115 USD | N/A | 9 working days | Get Quote |
| 10 mg | 117 USD | 99 | 15 working days | Get Quote |
New customers are eligible for a 10% discount if indicated at the time of ordering.
- 1-Click Docking Predict the binding orientation and affinity of the ligand to a target.
- Toxicity checker Searching for substructures commonly found in toxic and promiscuous ligands.
- Property calculator Create a physicochemical property profile for the compound in a second.
- Similarity search Find analogs by similarity search.
- Substructure search Find analogs by substructure search.
-
1
MCULE-1948703577
- Component type: Main
-
1
MCULE-7728164114
- Component type: Counter Ion
| Name | File |
|---|---|
| SDF | MCULE-7601911172.sdf |
| SMILES | MCULE-7601911172.smiles |
| Standard InChI | MCULE-7601911172.inchi |
| InChIKey | MCULE-7601911172.txt |
| mcule product ID | Supplier | Catalog | Guaranteed purity (%) | Product matching | Availability |
|---|---|---|---|---|---|
| P-854703569 | MedChemExpress | Screening compounds on demand | 95 | As is | by synthesis |
| P-869109287 | TargetMol | Screening Compounds - synthesis | 95 | As is | by synthesis |
| P-888627965 | TargetMol | Screening Compounds - stock amount | 95 | As is | unavailable |
| P-867593023 | A2B Chem | Predominantly Building Block in stock | 95 | Main component | in stock |
| P-875751962 | AA Blocks | AA Blocks - in stock | N/A | Main component | in stock |
| P-894668030 | AK Scientific | Building Blocks | 95 | Main component | in stock |
| P-893605015 | Advanced ChemBlocks Inc (AChemBlock) | In stock | 90 | Main component | 1000 mg |
| P-892509197 | AmBeed | In stock | N/A | Main component | in stock |
| P-895095074 | Angene | Building Blocks in stock | 98 | Main component | 500 mg |
| P-864303047 | AstaTech | Backordered BBs | 95 | Main component | by synthesis |
| P-892412009 | BLD pharm | In-stock building blocks | 99 | Main component | 135 mg |
| P-887187201 | Combi-Blocks | Building Block on demand | 95 | Main component | by synthesis |
| P-854711725 | MedChemExpress | Screening compounds In stock | 95 | Main component | in stock |
| P-888171249 | Molnova | On demand | 98 | Main component | by synthesis |
| P-869109286 | TargetMol | Screening Compounds - synthesis | 95 | Main component | by synthesis |
| P-892287196 | TargetMol | In Stock BB | 95 | Main component | unavailable |
| P-888627964 | TargetMol | Screening Compounds - stock amount | 95 | Main component | 4.825 g |
| P-855071192 | Toronto Research | In stock | 90 | Main component | in stock |
| P-893675059 | eNovation Chemicals LLC | Building Block on demand | 95 | Main component | by synthesis |
| Property | Value |
|---|---|
| Components | 2 |
| Mass | 465.930 |
| logP | 5.52108 |
| H-bond acceptors | 8 |
| H-bond donors | 1 |
| Rotatable bonds | 8 |
| PSA | 94.22 |
| RO5 violations | 1 |
| RO3 violations | 5 |
| Refractivity | 129.1787 |
| Atoms | 57 |
| Rings | 4 |
| Heavy atoms | 33 |
| Hydrogen atoms | 24 |
| Heteroatoms | 9 |
| N/O atoms | 8 |
| Inorganic atoms | 0 |
| Halogen atoms | 1 |
| Chiral centers | 0 |
| R/S chiral centers | 0 |
| Unknown chiral centers | 0 |
| Undefined chiral centers | 0 |
| Stereo double bonds | 0 |
| Cis/trans stereo double bonds | 0 |
| Unknown stereo double bonds | 0 |
| Undefined stereo double bonds | 0 |
